Singapore markets closed

Abeona Therapeutics Inc. (ABEO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.1400+0.7000 (+20.35%)
At close: 04:00PM EDT
4.1700 +0.03 (+0.72%)
Pre-market: 04:22AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,500
3,500
1,414
3,000
10,000
Cost of revenue
1,605
1,605
450
0
-
Gross profit
1,895
1,895
964
3,000
-
Operating expenses
Research development
31,091
31,091
28,965
38,726
30,139
Selling general and administrative
19,004
19,004
17,256
21,644
23,779
Total operating expenses
50,095
50,095
46,221
60,370
58,504
Operating income or loss
-48,200
-48,200
-45,257
-57,370
-48,504
Interest expense
418
418
736
3,656
4,115
Total other income/expenses net
-7,687
-7,687
5,866
-23,950
-32,916
Income before tax
-54,188
-54,188
-39,696
-84,936
-84,234
Income from continuing operations
-54,188
-54,188
-39,696
-84,936
-84,234
Net income
-54,188
-54,188
-39,696
-84,936
-84,234
Net income available to common shareholders
-54,188
-54,188
-43,478
-84,936
-84,234
Basic EPS
-1.37
-2.53
-5.53
-21.57
-22.75
Diluted EPS
-1.37
-2.53
-5.53
-21.57
-22.75
Basic average shares
18,311
21,380
7,862
3,938
3,707
Diluted average shares
18,311
21,380
7,862
3,938
3,707